Lilly Marks Major Milestone for Mirror Portfolio with Agreement by Independent Fund to License...
Eli Lilly and Company announced that the Mirror Portfolio, a concept created by Lilly to...
Gilead Sciences Refiles New Drug Application with the FDA for Single-Tablet Regimen of Truvada(R)...
Gilead Sciences, Inc. announced that it has refiled a New Drug Application (NDA) with the...
Elan and Boehringer Ingelheim Announce Development and Manufacturing Agreement for Elan’s Antibody-Based Therapeutics Pipeline
Elan plc and Boehringer Ingelheim announced that they have entered into a global technical development...
Cancer Can Be Prevented-Latest cancer preventability data released to mark World Cancer Day
On World Cancer Day, new independent evidence confirms that the increasing global trend of unhealthy...
Nycomed to acquire Colombian company Farmacol
Nycomed announced that it is expanding its presence in Latin America through the acquisition of...
Lilly and the Juvenile Diabetes Research Foundation Partner to Fund Regenerative Medicine Research in...
Eli Lilly and Company and the Juvenile Diabetes Research Foundation (JDRF) announced that they have...
Eisai Receives Complete Response Letter from FDA for Rabeprazole Sodium Extended-Release Capsules
Eisai announced that the company received a Complete Response Letter from the United States Food...
HCPC Alliance at Pharma Packaging & Labelling Compliance Conference
The pharmaceutical and consumers landscape is constantly evolving and the packaging requirements of the various...
15 Merck & Co senior executives join the eyeforpharma Sales Force Effectiveness forum
15 senior directors registered for eyeforpharma’s SFE 2011 (29-31 March, Dusseldorf) meeting. The Event Director...
Protagen at the Personalized Medicine and Diagnostics Europe Congress 2011
Protagen AG, a specialist for GMP-compliant protein analysis and in-vitro diagnostics is presenting at the...
